![Gaston-Dreyfus Remi buys 180,555 shares of Bionik Laboratories Corp. [BNKL]](/_next/image?url=https%3A%2F%2F10k-staging.s3.us-west-2.amazonaws.com%2Fnews_images%2Farticle_Bionik%2520Laboratories%2520Corp_20230421150665656.%2520%255BBNKL%255D&w=3840&q=75)
Gaston-Dreyfus Remi buys 180,555 shares of Bionik Laboratories Corp. [BNKL]
Transaction increases the holding of Gaston-Dreyfus Remi in the company to 1,814,871
By USInMinutes
Published - Jun 21, 2023, 11:04 AM ET
Last Updated - Jul 18, 2023, 03:08 PM EDT
Gaston-Dreyfus Remi has bought 180,555 shares of Bionik Laboratories Corp. [BNKL] at $0.60 a share.
Bionik Laboratories Corp. [BNKL] disclosed in an SEC Form 4 submission Friday, June 9, 2023 that the deal increased Gaston-Dreyfus Remi's holding in the company to 1,814,871.
Bionik Laboratories Corp. [BNKL] is a Orthopedic, Prosthetic & Surgical Appliances & Supplies company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Although all care is taken to ensure the accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications.
